Comparison of current diagnostic criteria for acute-on-chronic liver failure von Zhang, Qian, Li, Ying, Han, Tao, Nie, CaiYun, Cai, JunJun, Liu, Hua, Liu, Ying

Volltext

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study von Nie, Caiyun, Lv, Huifang, Xing, Yishu, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Chen, Xiaobing

Volltext

Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter r... von Nie, Caiyun, Xu, Weifeng, Guo, Yanwei, Gao, Xiaohui, Lv, Huifang, Chen, Beibei, Wang, Jianzheng, Liu, Yingjun, Zhao, Jing, Wang, Saiqi, He, Yunduan, Chen, Xiaobing

Volltext

Adding of apatinib and camrelizumab to overcome de novo trastuzumab resistance of HER2-positive gastric cancer: A case report and literature review von Lv, Huifang, He, Yunduan, Nie, Caiyun, Du, Feng, Chen, Xiaobing

Volltext

Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above thera... von Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Liu, Yingjun, Wang, Saiqi, Zhao, Jing, He, Yunduan, Chen, Xiaobing

Volltext

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma von Xu, Weifeng, Nie, Caiyun, Lv, Huifang, Chen, BeiBei, Wang, Jianzheng, Wang, Saiqi, Zhao, Jing, He, Yunduan, Chen, Xiaobing

Volltext

Clinical Study of Sintilimab as Second-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Retrospective Study von Nie, Caiyun, Lv, Huifang, Liu, Yingjun, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Chen, Xiaobing

Volltext

Real‐world effectiveness and safety of RC48‐ADC alone or in combination with PD‐1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma: A multicenter, r... von Xu, Jingwei, Zhang, Hongqiao, Zhang, Li, Chu, Xiufeng, Li, Yu, Li, Guangyuan, Nie, Caiyun, Wang, Meng, Guo, Yanwei

Volltext

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer von Chen, Beibei, Zhao, Huichen, Huang, Jinxi, Lv, Huifang, Xu, Weifeng, Nie, Caiyun, Wang, Jianzheng, Zhao, Jing, He, Yunduan, Wang, Saiqi, Chen, Xiaobing

Volltext

In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer von Wang, Hui, Nie, Caiyun, Xu, Weifeng, Li, Jing, Gou, He, Lv, Huifang, Chen, Beibei, Wang, Jianzheng, Liu, Yingjun, He, Yunduan, Zhao, Jing, Chen, Xiaobing

Volltext

A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report von Wang, Jianzheng, Li, Qingli, Lv, Huifang, Nie, Caiyun, Chen, Beibei, Xu, Weifeng, Yang, Tiejun, Zhang, Yinping, Tu, Shuiping, Chen, Xiaobing

Volltext

Predictors of progression into acute-on-chronic liver failure from acute deterioration of pre-existing chronic liver disease von Zhang, Qian, Han, Tao, Li, Ying, Nie, CaiYun, Liu, Hua

Volltext

Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer von Lv, Huifang, Zhang, Junling, Sun, Keran, Nie, Caiyun, Chen, Beibei, Wang, Jianzheng, Xu, Weifeng, Wang, Saiqi, Liu, Yingjun, Chen, Xiaobing

Volltext

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer von Wang, Jianzheng, He, Yunduan, Zhang, Baiwen, Lv, Huifang, Nie, Caiyun, Chen, Beibei, Xu, Weifeng, Zhao, Jing, Cheng, Xiaojiao, Li, Qingli, Tu, Shuiping, Chen, Xiaobing

Volltext

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study von Nie, Caiyun, Xu, Weifeng, Lv, Huifang, Gao, Xiaohui, Li, Guofeng, Chen, Beibei, Wang, Jianzheng, Liu, Yingjun, Zhao, Jing, He, Yunduan, Wang, Saiqi, Chen, Xiaobing

Volltext

High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study von Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Wang, Saiqi, Liu, Yingjun, He, Yunduan, Zhao, Jing, Chen, Xiaobing

Volltext

Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications von Zhao, Huichen, Hu, Huihui, Chen, Beibei, Xu, Weifeng, Zhao, Jing, Huang, Chen, Xing, Yishu, Lv, Huifang, Nie, Caiyun, Wang, Jianzheng, He, Yunduan, Wang, Sai-Qi, Chen, Xiao-Bing

Volltext

Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study von Nie, Caiyun, He, Yunduan, Lv, Huifang, Gao, Ming, Gao, Xiaohui, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Liu, Yingjun, Zhao, Jing, Chen, Xiaobing

Volltext

Corrigendum: Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer von Lv, Huifang, Zhang, Junling, Sun, Keran, Nie, Caiyun, Chen, Beibei, Wang, Jianzheng, Xu, Weifeng, Wang, Saiqi, Liu, Yingjun, Chen, Xiaobing

Volltext

Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer von Chen, Beibei, Wang, Sai-Qi, Huang, Jinxi, Xu, Weifeng, Lv, Huifang, Nie, Caiyun, Wang, Jianzheng, Zhao, Huichen, Liu, Yingjun, Li, Jitian, Lu, Canrong, Zhang, Jianying, Chen, Xiao-Bing

Volltext